Luke Engelking

Background

About Luke Engelking

Dr. Engelking a physician-scientist gastroenterologist, investigator, and educator. He serves as the clinic, endoscopy, and research lead of the Hereditary GI Cancer and Polyposis program, which focuses on cancer prevention for patients and their families with inherited forms of GI cancers, especially colorectal cancer. He has completed intensive training from City of Hope and is a certified genetic cancer risk assessment specialist. He completed joint MD/PhD training at UT Southwestern in Dallas, where he studied cholesterol metabolism under Nobel Laureates Goldstein and Brown. He next completed internal medicine training at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School, and then returned to UT Southwestern for a clinical and research fellowship in gastroenterology (2010-2014). He is now an Associate Professor of Internal Medicine, Molecular Genetics, the Center for Human Nutrition, and the Simmons Comprehensive Cancer Center. He serves as Associate Dean of Medical Student Research and Scholarly Activity (interim). His basic science laboratory studies various aspects of lipid metabolism in digestive organs and GI tract neoplasms and is supported by research grants from NIH and CPRIT. He has authored numerous high impact research manuscripts published in Journal of Clinical Investigation, Cell Metabolism, and elsewhere.